| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |